Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Deal Volume On The Rise Heading Into J.P. Morgan

Jan 07 2021

• By Joseph Haas and Alexandra Shimmings

DealWatch_1200x675

Related Content

‘We’re On The Edge Of Knowledge,’ Says Dewpoint CEO

Oct 13 2020

AmerisourceBergen Strikes $6.5bn Deal For Alliance

Jan 07 2021

Endo’s Par Opts For Authorized Generic As It Debuts Lubiprostone In US

Jan 05 2021

Argenx Advances Efgartigimod Into China With Zai Lab Pact

Jan 07 2021

Roche Inks RNA-Targeted Small Molecule Pact With Ribometrix

Jan 06 2021

Deal Watch: Early 2020 Deal-Making Boom Starts With Third Bayer/Evotec R&D Alliance

Jan 09 2020

Lilly’s Paying $1.1bn For Itch Advantage With Dermira’s Lebrikizumab

Jan 10 2020

Faze Is Newest Swimmer In Pool of Biotechs Targeting Biomolecular Condensates

Dec 10 2020

ADCs, Oncology Move To Fore In Korean Biopharma Alliances

Jan 05 2021

Related Companies

Dewpoint Therapeutics

Pfizer Inc.

Faze Medicines

Nurix Therapeutics, Inc.

Sanofi

Bristol Myers Squibb Company

Arsenal Biosciences, Inc.

Almirall SA

Eli Lilly and Company

Dermira Inc.

Evommune, Inc.

Gilead Sciences, Inc.

Kite Pharma, Inc.

Oxford BioTherapeutics

X-Chem, Inc.

Radius Health, Inc.

Benuvia Therapeutics, Inc.

Revitope Oncology, Inc.

Janssen Biotech Inc.

VeonGen Therapeutics

Entero Therapeutics, Inc.

First Wave Bio, Inc.

Additional Topics

Deals Business Strategies Commercial BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window